id=241160711 The prominent players of global Cattle & porcine/swine reproductive diseases market are Zoetis Inc. (US), Merck & Co., Inc. (US), Boehringer Ingelheim International GmBH (Germany ...

An interim analysis from a long-term open-label extension study has underlined the clinical efficacy and safety of ...

A persistent, often progressive, lung disease, COPD results from chronic inflammation that leads to structural changes ...

Interview with Nicolas Poirier, CEO at OSE Immunotherapeutics a biotech with a compound that is a therapeutic cancer vaccine, ...

According to a Reuters report, the company has now overtaken Bayer as the largest Germany-headquartered pharma group. For 2024, Boehringer said it expects a “slight” year-on-year increase in ...

She rose through the ranks and worked with various companies, including pharmaceutical company Boehringer Ingelheim ... Like, ...

Advances in Therapy to Address Proteinuria in Patients with Immunoglobulin A Nephropathy. As the majority of patients with ...

The global Cattle & Porcine/Swine Reproductive Diseases market is expected to grow to USD 975.8 Million by 2029, up from USD ...

According to a recent report by Future Market Insights (FMI), the global Rx-to-OTC switches market is projected to experience exceptional growth, reaching a valuation of USD 66.5 billion by 2033. This ...

Knowledge on the genetic basis of Parkinson's disease has grown tremendously since the discovery of the first monogenic form, ...

In this report, the cattle & porcine/swine reproductive diseases market is segmented into product type, diseases type, animal type, end user type and region. Based on product type, the cattle ...